Amerise Biosciences Ltd.

0.63 0.00

08 December 2023, 04:00:00 PM
Volume: 115,778

Company Profile

Sector Finance Sector Icon Finance Compare with Sector peers
Industry Finance - Investment Industry Icon Finance - Investment Compare with Industry peers
Website http://www.amerisebiosciencesltd.shop
Market Cap 4.16 Cr.
Enterprise Value(EV) Cr. -
Financial Indicators
Earnings per share (EPS) -0.03 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 15.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 0.82 Trailing Twelve Months Ending 2023-09
Price to Book Value 0.77 Calculated using Price: 0.63
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 6.61 Cr. 66,069,000 Shares
FaceValue 1
About Amerise Biosciences Ltd.
The company is engaged in commodity trading and in financial year (FY) 2007 it entered into the trading of castor seeds.

Amerise Biosciences Ltd. Delivery

Delivered Qty
Traded Qty

Amerise Biosciences Ltd. Performance

1 Day
1 Week
+8.62%
1 Month
+8.62%
3 Month
-3.08%
6 Month
-5.97%
1 Year
-35.05%
2 Year
-57.72%
5 Year
-30.0%
10 Year
-89.50%

Amerise Biosciences Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -0.72 -0.43 -15.50 -0.38 0.07 -2.71 -6.41 10.24 -2.13
Return on Capital Employed (%) -0.68 -0.43 -15.50 -0.38 0.07 -2.70 -6.41 10.17 -2.10
Return on Assets (%) -0.69 -0.43 -15.43 -0.38 0.07 -2.56 -5.79 6.24 -1.35

Amerise Biosciences Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 7 6 6 6 5 5 6 6 5
Non Curr. Liab. 0 0 0
Curr. Liab. 0 0 0 0 1 1 6 0 0
Minority Int.
Equity & Liab. 7 7 6 6 6 6 6 12 6 6
Non Curr. Assets 3 6 3 3 1 6 6 6 6 6
Curr. Assets 4 0 3 3 4 0 0 6 0 0
Misc. Exp. not W/O
Total Assets 7 7 6 6 6 6 6 12 6 6

Amerise Biosciences Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 1 9
Other Income 1 0
Total Income 1 10 0
Total Expenditure 0 0 -1 0 -1 0 0 -9 0 0
PBIDT 0 0 -1 0 0 0 1 0 0
Interest
Depreciation
Taxation
Exceptional Items
PAT 0 0 -1 0 0 0 1 0 0
Adjusted EPS 0 0 0 0 0 0 0

Amerise Biosciences Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 0 1 -4 0 -2 5 0 0 0
Cash Fr. Inv. -1 0 -1 4 0 2 -5 0 0 0
Cash Fr. Finan. -2 -1 0 0
Net Change 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Amerise Biosciences Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Amerise Biosciences Ltd. Announcements

Tue, 07 Nov 2023
Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
PFA
Tue, 07 Nov 2023
Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations 2015.
In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith Un-audited financial result for quarter and half year ended on 30th September 2023 andThe meeting commenced at 04.00P.M. and concluded at 04.30 P.M.Kindly take the same on your record and oblige.Thanking You
Thu, 26 Oct 2023
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.
Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Tuesday November 7 2023 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records.Thanking you.

Amerise Biosciences Ltd. Technical Scans

Fri, 08 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

Amerise Biosciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Life Insurance Corporation of India 489,428.32 773.80 -1.5%
Bajaj Finance Ltd. 451,580.19 7,306.85 -1.2%
Bajaj Finserv Ltd. 272,868.47 1,710.25 +0.4%
JIO Financial Services Ltd. 155,242.50 244.25 -2.0%
SBI Life Insurance Company Ltd. 146,830.30 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. 144,589.61 672.40 -0.8%
Power Finance Corporation Ltd. 127,070.42 384.60 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-09 12.48 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-09 34.42 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-09 36.76 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 0.00 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-09 79.70 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-09 98.17 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-09 7.08 384.60 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-09 7.89 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-09 6.58 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-09 5.36 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 1.34 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-09 10.51 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-09 10.58 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-09 1.36 384.60 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Life Insurance Corporation of India Consolidated 2023-03 0.00 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-03 4.03 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-03 4.60 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 0.01 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 0.00 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-03 0.07 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-03 8.92 384.60 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-03 124.33 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-03 23.70 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-03 28.46 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 0.06 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 14.14 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-03 9.60 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-03 27.18 384.60 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-03 124.33 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-03 23.70 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-03 28.46 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 0.06 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 14.14 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-03 9.60 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-03 27.18 384.60 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-03 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-03 41,397.38 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-03 82,071.24 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 41.63 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-03 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-03 77,766.05 384.60 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Life Insurance Corporation of India Consolidated 2023-03 35,996.65 773.80 -1.5%
Bajaj Finance Ltd. Consolidated 2023-03 11,507.69 7,306.85 -1.2%
Bajaj Finserv Ltd. Consolidated 2023-03 12,209.54 1,710.25 +0.4%
JIO Financial Services Ltd. Consolidated 2023-03 31.25 244.25 -2.0%
SBI Life Insurance Company Ltd. Standalone 2023-03 1,720.57 1,466.60 +0.7%
HDFC Life Insurance Company Ltd. Consolidated 2023-03 1,368.28 672.40 -0.8%
Power Finance Corporation Ltd. Consolidated 2023-03 21,178.59 384.60 +2.0%

Amerise Biosciences Ltd. FAQ's

What is Amerise Biosciences share price?

Can I buy Amerise Biosciences shares now?

What is the Market Cap of Amerise Biosciences?

What are the key metrics to analyse Amerise Biosciences?

What is the 52 Week High and Low of Amerise Biosciences?

What is the trend of Amerise Biosciences share price?